RWM
PPH icon

RMG Wealth Management’s VanEck Pharmaceutical ETF PPH Stock Holding History

RMG Wealth Management’s Portfolio PPH Stock Details PPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-4
Closed -$415 – 679
2026
Q1 		$415 Buy
+4
New +$426 ﹤0.01% 567

Other funds holding PPH

Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
JSAM
J. Safra Asset Management New York $2.17B AUM 29.66% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
AT
Avalon Trust Santa Fe, New Mexico $1.63B AUM 42.75% 1-Year Est. Return
AWC
Adamsbrown Wealth Consultants Wichita, Kansas $530M AUM 23.21% 1-Year Est. Return

RMG Wealth Management's PPH Position: Q2 2026 in Review

RMG Wealth Management sold out of VanEck Pharmaceutical ETF (PPH) in Q2 2026, closing a stake of 4 shares — an estimated $415 sold.

RMG Wealth Management first reported a position in PPH in Q1 2026 and held it in 1 quarter. The position peaked at $415 in Q1 2026. 148 funds tracked by Wall St. Rank hold PPH as of Q2 2026.

  • RMG Wealth Management reported no remaining VanEck Pharmaceutical ETF position as of Q2 2026 after selling out during the quarter.
  • RMG Wealth Management sold 4 VanEck Pharmaceutical ETF shares in Q2 2026, an estimated $415.
  • RMG Wealth Management first reported a position in VanEck Pharmaceutical ETF in Q1 2026 and held it in 1 quarter.
  • RMG Wealth Management's VanEck Pharmaceutical ETF position peaked at $415 in Q1 2026.
  • 148 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2026.

Based on RMG Wealth Management's 13F filing for Q2 2026, filed 13 Aug 2026.